Partnership agreement between Croda and AAHI to drive innovation in vaccine development
Croda International Plc has confirmed that, following receipt of unconditional approval from the South Korean regulatory authorities, it has now successfully completed the acquisition of Solus Biotech, a global leader in premium, biotechnology-derived active ingredients for beauty care and pharmaceuticals.
Croda International has entered into an agreement with the U.S. government in which the government will provide up to $75 million to expand the company's U.S. manufacturing capacity of ingredients for lipid systems used in novel therapeutic drugs, such as mRNA vaccines.
Croda International Plc ('Croda' or 'the company'), the company that uses smart science to create high performance ingredients and technologies that...
(Reuters) - Croda International has entered into a deal with Pfizer Inc to supply additives for manufacturing its COVID-19 vaccine candidate, the UK-based specialty chemical company said on Tuesday, sending its shares to a record high.
This report analyzes and forecasts the market for excipients at the global and regional level. The market has been forecast based on volume (tons) and revenue (US$ Thousand) from 2015 to 2023. The study includes drivers and restraints of the global excipients market. It also covers the impact of these drivers and restraints on demand for excipients during the forecast period. The report also highlights opportunities in the excipients market at the global and regional level.